Vaccine Choice Canada

Your Child. Your Future. Your Choice.

Donate Button
  • About Vaccines
    • Vaccination: Basic Concerns
      • Children’s Health in Decline
      • Contraindications to Vaccination
      • Parent’s Guide to Vaccination
      • Adverse Events – Unreported
      • Disease Trends
    • General Issues
      • Informed Consent – Mature Minor – Ethics
      • Politics of Vaccination
      • Healthcare Worker & Student Vaccines
      • Herd Immunity
      • Doctors Speak
      • Parents Speak
      • Reports
    • Specific Vaccines
    • Vaccine Ingredients
  • Health Risks
  • Science
  • Exemptions
    • Legal Exemption Forms
    • Canadian Medical Law
    • Ontario Daycare Exemptions
    • Immunization Not Mandatory in Canada
    • Threats to Exemptions
    • Take Action / Events
  • Personal Stories
  • Alternatives
    • Alternatives – Specific Infections
  • Articles
  • Resources
    • Child Health Links
    • Pro-vaccine websites
    • Video & Audio
  • Home
  • About VCC
    • Policy Statement on Vaccination
    • Who We Are & What We Do
    • VCC History
    • Privacy Policy
    • Disclaimer
  • Join
  • Report a Reaction
  • Bookstore
  • Contact
  • Member’s Area
    • Journal Archive
  • Site Map
  • Media
You are here: Home / About Vaccines / Adverse Events / Multiple Sclerosis Risk to British Babies Health

Multiple Sclerosis Risk to British Babies Health

September 27, 2005 By Vaccine Choice Canada

27 September 2005.
NEWS RELEASE

Multiple Sclerosis Risk to British Babies – Newly Revealed By Previously Concealed Evidence

London, England & Versailles, France 27 September 2005/Romeike/

Strong scientific evidence confirms British infants will be exposed to an unacceptably high risk of complications, including multiple sclerosis, if the British Medical Association’s (BMA’s) recent universal infant hepatitis B vaccine recommendation goes ahead. Whilst other evidence is embargoed, Dr. Marc Girard, a specialist in the side effects of drugs and commissioned as a medical expert by French courts, has been able to publish a scientific review of the unembargoed evidence of the vaccine’s hazards (Autoimmun Rev 2005; 4:96-100). Dr Girard shows that French health authorities suppress studies demonstrating serious risks. France was the first country to implementuniversal hepatitis B vaccination in 1994.

Legal and ethical concerns also arise over the BMA’s recommendation because those at high risk from the hepatitis B virus are not infants but promiscuous adults engaging in unsafe sex and intravenous drug abusers. There is no clear individual clinical benefit of universal hepatitis B vaccination. The duration of any protective effect is uncertain whereas the vaccination carries with it risks of numerous chronic auto-immune disorders, including Guillain-Barre syndrome, lupus, rheumatism, blood disorders and chronic fatigue. In contrast, the BMA’s 10th May 2005 press release stated children were at risk of hepatitis B infection from:

  • biting and shared toys
  • shared toothbrushes and razors
  • mother to child transmission during birth

Dr Girard said:

“The BMA’s recommendation is a surprising and unexpected change of heart given the scathing public scepticism in the British Medical Journal in 1996 to a pharmaceutical company promotion advocating universal infant hepatitis B vaccination (BMJ 1996; 313: 825). It is all the more surprising because whilst the risk factors for babies have changed little, there is now impressive evidence that for a preventive measure, hepatitis B vaccine is remarkable for the frequency, variety and severity of complications from its use. The toxicity of this vaccine is so unusual that, even if crucial data are regrettably concealed or covered by Court order, scientific evidence is already far higher than normally needed to justify severe restrictive measures.”

In addition, just days ago (20 Sept, 2005) the European Medicines Agency EMEA) announced the withdrawal of hepatitis B containing Hexavac vaccine, claiming concerns over efficacy. Hexavac had 4 months earlier been associated with sudden infant deaths (Zinka et al. Vaccine 2005 May 18). Hexavac combines hepatitis B vaccine virus with other routine vaccine components. The EMEA’s reasons for withdrawal are questionable. Efficacy trials are normally performed before vaccines are licensed.

Other research supporting Dr Girard’s findings includes research on UK data showing a 3.1 increase in the relative risk of multiple sclerosis after hepatitis B vaccination Neurology 2004; 63:838-42).

Clifford Miller, British lawyer, graduate physicist, co-author of a recent peer reviewed critique of flawed medical evidential practice and former university lecturer said:-

“British Doctors administering hepatitis B vaccine to infants could face criminal prosecution if fully informed consent is not obtained.Civil prosecution for damages is possible over 21 years later if the injured survive as adults.”

“English and European law requires the application of the precautionary principle. With such strong scientific evidence of harm it is unclear why the BMA’s recommendation was made, nor why universal infant hepatitis B vaccination is reportedly being considered by the UK Joint Committee on Vaccination and Immunisation.”

“This is not the first time the BMA has executed a spectacular `U’ turn. Up to 1987 they consistently recommended against mumps vaccination. In 1988 that conflicted with new government policy and the objection was quietly dropped. The BMA’s links with the pharmaceutical industry are also a concern. The next government proposal in the pipeline is to vaccinate against chickenpox, the mildest known of all routine childhood diseases and for which the UK Department of Health has ready prepared stories claiming it is a killer.”

“The British public should be concerned their children’s safety rests with independent researchers from overseas who can face harassment, obstruction and official vilification for their work.”

In his new paper now in press and available on line (Med Hypotheses, doi 10.1016/j.mehy.2005.08.012), Dr Girard and co-author Y. Comenge review the various mechanisms likely to account for the biological plausibility of auto-immune disorders such as demyelinating diseases and other hazards of this vaccine.

Because of the significance and scope of these observations and related cross- correlations, Dr. Girard suggests that even in high-endemic countries, the risk/benefit ratio of this unusually toxic vaccine must be carefully re-assessed. Regarding the health situation in the UK, the conclusion not to vaccinate is obvious.

INFORMATION FOR EDITORS:

About Dr Marc Girard

Pharmaceutical Industry Consultant: Glaxo, Aventis & others
Court Appointed Expert: Includes Bayer/Baycol cholesterol drug litigation
Medical Doctor: Qualified 1983, trained: Hopital des Enfants Malades, Paris, France
Masters in Mathematics 1976: Universite d’Orsay, Paris, France

References Used in Press Release

  • “Multiple sclerosis and hepatitis B vaccination: Adding the credibility of molecular biology to an unusual level of clinical and epidemiological evidence” Comenge Y; Girard M (Med Hypotheses, doi 10.1016/j.mehy.2005.08.012) (Text available in electronic form on request.)
  • “Autoimmune hazards of hepatitis B vaccine” Girard M (Autoimmun Rev 2005; 4:96-100) (Text available in electronic form on request.)
  • “Medicine and the media: Shire Hall Communications and the case for hepatitis B immunisation” BMJ 1996;313:825 (28 September 1996)
  • “European Medicines Agency recommends suspension of Hexavac” Press Release – 20th September 2005
  • “Unexplained cases of sudden infant death shortly after hexavalent vaccination” Zinka B, Rauch E, Buettner A, Rueff F, Penning R. – Vaccine. 2005 May 18
  • “Recombinant hepatitis B vaccine and the risk of multiple sclerosis – A prospective study” Hernan MA, Jick SS, Olek MJ, Jick H (Neurology 2004; 63:838-42).
  • “Flawed Evidence Denies Drug Victims Justice” – Press Release, Romeike/PA
  • “On Evidence, Medical and Legal” Dr D W Miller, Clifford Miller: – 10; 03- 70. J Am Phys Surg

Contact information

Dr. Marc Girard
Address: 1 bd de la Republique 78000-Versailles (France)
Mobile phone: 00 33 6 82 94 54 62
E-Mail: agosgirard@free.fr
Telephone: 00 331 39670110
Fax : 00 331 396700111

Mr. Clifford G. Miller
Address: Burnhill Business Centre,
50 Burnhill Road,
Beckenham,
Kent BR3 3LA (UK)
Mobile: 00 44 7941-976021
E-Mail: mediapr@cliffordmiller.com
Telephone: 00 44 208 663 0044
Fax: 00 44 208 663 0011

Further Reading:

Dr. Marc Girard’s work on Hepatitis B published in Medical Hypothesis http://www.nccn.net/~wwithin/girardhepbvax.pdf

Share this:

Filed Under: Adverse Events, Doctors Speak, Hepatitis-B Vaccine, SIDS-SBS Tagged With: Hepatitis-B Vaccine, multiple sclerosis, Sudden Infant Death

Articles by Category

  • About Vaccines
    (179)
    • Adverse Events
      (106)
    • Compensation
      (6)
    • Contraindications
      (1)
    • Herd Immunity
      (11)
    • Informed Consent – Mature Minor – Ethics
      (80)
    • Reports
      (13)
  • Disease Trends
    (27)
  • Doctors Speak
    (54)
  • Exemptions
    (171)
    • Take Action
      (111)
    • Threats to Exemptions
      (153)
  • Health Risks
    (147)
    • Anaphylaxis, Allergies, and Asthma
      (26)
    • Autism
      (55)
    • Brain and Neurological Injuries
      (37)
    • Cancer
      (3)
    • Decline in Children's Health
      (26)
    • Gulf War Syndrome
      (4)
    • Infertility
      (1)
    • Obesity and Diabetes
      (4)
    • Pregnancy – Risks to the Foetus
      (5)
    • SIDS-SBS
      (12)
  • Media
    (83)
  • Parents Speak
    (32)
  • Personal Stories
    (28)
  • Politics of Vaccination
    (40)
  • Resources
    (61)
    • Books & Periodicals
      (1)
    • PDF files
      (3)
    • Videos
      (0)
  • Specific Vaccines
    (228)
    • Chickenpox and Shingles Vaccines
      (12)
    • COVID-19 Vaccine
      (10)
    • Diphtheria, Tetanus, Pertussis, and Hib Vaccine
      (38)
    • Healthcare Worker & Student Vaccines
      (15)
    • Hepatitis-B Vaccine
      (20)
    • HPV Vaccine
      (19)
    • Influenza Vaccine
      (46)
    • Measles, Mumps, & Rubella Vaccine
      (47)
    • Meningococcal Disease Vaccine
      (9)
    • Pet Vaccines
      (1)
    • Pneumococcal Disease Vaccine
      (4)
    • Polio Vaccine
      (13)
    • Rotavirus Vaccine
      (1)
    • Smallpox Vaccine
      (4)
    • Travel Vaccines
      (1)
  • Vaccine Alternatives
    (13)
    • Vaccine Alternatives – General
      (7)
    • Vaccine Alternatives – Specific Infections
      (6)
  • Vaccine Ingredients
    (69)
    • Aluminum
      (23)
    • Biological Ingredients
      (15)
    • Chemical Ingredients
      (15)
    • Food Allergens
      (4)
    • Mercury
      (24)
    • Oil-based Adjuvants
      (11)

Join Vaccine Choice Canada

To support our educational and outreach work , please join Vaccine Choice Canada today. Sign Me Up!

Log In


Lost your password?

About Vaccine Choice Canada

Vaccine Choice Canada is a volunteer run, federally registered … read more

Our Mission

Vaccine Choice Canada (formerly VRAN) continues the work of … more

Disclaimer

The contents of this website are for informational purposes … more

Vaccine Choice Canada logo

Find More on

  • Decline in Children's Health
    (26)
  • Doctors Speak
    (54)
  • Exemptions
    (130)
  • Health Risks
    (39)
  • Parents Speak
    (32)
  • Personal Stories
    (28)
  • Resources
    (60)
  • Specific Vaccines
    (92)
  • Vaccine Alternatives
    (8)
  • Vaccine Ingredients
    (22)

Personal Stories

Susan’s Flu Vaccine Reaction

In 2013, I contracted the H1N1 strain of flu.  I was deathly … [Read More...]

My Journey with Vaccine Awareness and a closer look at Vaxxed vs. Unvaxxed

I was born in the mid 1980’s and was fully vaccinated as a … [Read More...]

A story of my grandson’s visit, discovery of his autism, and how he recovered

By Shanna Mi    November 2019 It was a glorious late … [Read More...]

Laura’s Story

July 2002 Today is my daughter's sweet 16th birthday but … [Read More...]

More Personal Stories

Featured Articles

COVID-19

COVID-19 Resources (printable) & Take Action – Letter … [Read More...]

News Nuggets April 2, 2021 – Top News Items

Compiled by Edda West FEATURES Naomi Wolf speaks to … [Read More...]

News Nuggets March 26, 2021- Top News Items

Compiled by Edda West FEATURES Vera Sharav - Holocaust … [Read More...]

Media Release – VCC Releases Recommendations for Vaccine Injury Accountability and Compensation Program

Send this press release to your local newspaper, elected … [Read More...]

More News Articles

Copyright © 2021 Vaccine Choice Canada